List of Tables

Table 1. Mucormycosis Treatment Drugs Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Mucormycosis Treatment Drugs Market Restraints

Table 3. Mucormycosis Treatment Drugs Market Trends

Table 4. Mucormycosis Treatment Drugs Industry Policy

Table 5. Global Mucormycosis Treatment Drugs Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Mucormycosis Treatment Drugs Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Mucormycosis Treatment Drugs Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 8. Global Mucormycosis Treatment Drugs Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Mucormycosis Treatment Drugs Average Selling Price (ASP) by Company, (2020-2025) & (US$/Unit)

Table 10. Global Mucormycosis Treatment Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Mucormycosis Treatment Drugs Mergers & Acquisitions, Expansion Plans

Table 12. Global Mucormycosis Treatment Drugs Manufacturers Product Type

Table 13. Head Office and Mucormycosis Treatment Drugs Production Site of Key Manufacturer

Table 14. Mucormycosis Treatment Drugs Capacity of Major Manufacturers and Future Plan

Table 15. China Mucormycosis Treatment Drugs Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Mucormycosis Treatment Drugs Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Mucormycosis Treatment Drugs Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 18. China Mucormycosis Treatment Drugs Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Mucormycosis Treatment Drugs Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Units)

Table 20. Global Mucormycosis Treatment Drugs Production by Region, 2020-2025, (K Units)

Table 21. Global Mucormycosis Treatment Drugs Production Forecast by Region, 2026-2031, (K Units)

Table 22. Global Key Players of Mucormycosis Treatment Drugs Upstream (Raw Materials)

Table 23. Global Mucormycosis Treatment Drugs Typical Customers

Table 24. Mucormycosis Treatment Drugs Typical Distributors

Table 25. by Type, Global Mucormycosis Treatment Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Mucormycosis Treatment Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Mucormycosis Treatment Drugs Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Mucormycosis Treatment Drugs Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Mucormycosis Treatment Drugs Sales Quantity, 2020-2031, (K Units)

Table 30. By Country, Global Mucormycosis Treatment Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Mucormycosis Treatment Drugs Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Mucormycosis Treatment Drugs Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Mucormycosis Treatment Drugs Sales Quantity, 2020-2031, (K Units)

Table 34. By Country, Global Mucormycosis Treatment Drugs Sales Quantity Market Share, 2020-2031

Table 35. Abbott Laboratories Company Information, Head Office, Market Area, and Industry Position

Table 36. Abbott Laboratories Mucormycosis Treatment Drugs Models, Specifications, and Application

Table 37. Abbott Laboratories Mucormycosis Treatment Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 38. Abbott Laboratories Company Profile and Main Business

Table 39. Abbott Laboratories Recent Developments

Table 40. Biocon Company Information, Head Office, Market Area, and Industry Position

Table 41. Biocon Mucormycosis Treatment Drugs Models, Specifications, and Application

Table 42. Biocon Mucormycosis Treatment Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 43. Biocon Company Profile and Main Business

Table 44. Biocon Recent Developments

Table 45. Cadila Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 46. Cadila Pharmaceuticals Mucormycosis Treatment Drugs Models, Specifications, and Application

Table 47. Cadila Pharmaceuticals Mucormycosis Treatment Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 48. Cadila Pharmaceuticals Company Profile and Main Business

Table 49. Cadila Pharmaceuticals Recent Developments

Table 50. Novartis Company Information, Head Office, Market Area, and Industry Position

Table 51. Novartis Mucormycosis Treatment Drugs Models, Specifications, and Application

Table 52. Novartis Mucormycosis Treatment Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 53. Novartis Company Profile and Main Business

Table 54. Novartis Recent Developments

Table 55. F. Hoffman La Roche Company Information, Head Office, Market Area, and Industry Position

Table 56. F. Hoffman La Roche Mucormycosis Treatment Drugs Models, Specifications, and Application

Table 57. F. Hoffman La Roche Mucormycosis Treatment Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 58. F. Hoffman La Roche Company Profile and Main Business

Table 59. F. Hoffman La Roche Recent Developments

Table 60. Merck Sharp and Dohme Company Information, Head Office, Market Area, and Industry Position

Table 61. Merck Sharp and Dohme Mucormycosis Treatment Drugs Models, Specifications, and Application

Table 62. Merck Sharp and Dohme Mucormycosis Treatment Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 63. Merck Sharp and Dohme Company Profile and Main Business

Table 64. Merck Sharp and Dohme Recent Developments

Table 65. Mylan Labs Company Information, Head Office, Market Area, and Industry Position

Table 66. Mylan Labs Mucormycosis Treatment Drugs Models, Specifications, and Application

Table 67. Mylan Labs Mucormycosis Treatment Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 68. Mylan Labs Company Profile and Main Business

Table 69. Mylan Labs Recent Developments

Table 70. Bristol Myers Squibb Company Information, Head Office, Market Area, and Industry Position

Table 71. Bristol Myers Squibb Mucormycosis Treatment Drugs Models, Specifications, and Application

Table 72. Bristol Myers Squibb Mucormycosis Treatment Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 73. Bristol Myers Squibb Company Profile and Main Business

Table 74. Bristol Myers Squibb Recent Developments

Table 75. Bayer Company Information, Head Office, Market Area, and Industry Position

Table 76. Bayer Mucormycosis Treatment Drugs Models, Specifications, and Application

Table 77. Bayer Mucormycosis Treatment Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 78. Bayer Company Profile and Main Business

Table 79. Bayer Recent Developments

Table 80. Lonza Group Company Information, Head Office, Market Area, and Industry Position

Table 81. Lonza Group Mucormycosis Treatment Drugs Models, Specifications, and Application

Table 82. Lonza Group Mucormycosis Treatment Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 83. Lonza Group Company Profile and Main Business

Table 84. Lonza Group Recent Developments

Table 85. Sanofi Company Information, Head Office, Market Area, and Industry Position

Table 86. Sanofi Mucormycosis Treatment Drugs Models, Specifications, and Application

Table 87. Sanofi Mucormycosis Treatment Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 88. Sanofi Company Profile and Main Business

Table 89. Sanofi Recent Developments

Table 90. Johnson and Johnson Company Information, Head Office, Market Area, and Industry Position

Table 91. Johnson and Johnson Mucormycosis Treatment Drugs Models, Specifications, and Application

Table 92. Johnson and Johnson Mucormycosis Treatment Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 93. Johnson and Johnson Company Profile and Main Business

Table 94. Johnson and Johnson Recent Developments

Table 95. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 96. Pfizer Mucormycosis Treatment Drugs Models, Specifications, and Application

Table 97. Pfizer Mucormycosis Treatment Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 98. Pfizer Company Profile and Main Business

Table 99. Pfizer Recent Developments

Table 100. Gilead Sciences Company Information, Head Office, Market Area, and Industry Position

Table 101. Gilead Sciences Mucormycosis Treatment Drugs Models, Specifications, and Application

Table 102. Gilead Sciences Mucormycosis Treatment Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 103. Gilead Sciences Company Profile and Main Business

Table 104. Gilead Sciences Recent Developments

List of Figures

Figure 1. Mucormycosis Treatment Drugs Picture

Figure 2. Global Mucormycosis Treatment Drugs Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Mucormycosis Treatment Drugs Sales Quantity, (K Units) & (2020-2031)

Figure 4. Global Mucormycosis Treatment Drugs Average Selling Price (ASP), (2020-2031) & (US$/Unit)

Figure 5. China Mucormycosis Treatment Drugs Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Mucormycosis Treatment Drugs Sales Quantity (K Units) & (2020-2031)

Figure 7. China Mucormycosis Treatment Drugs Average Selling Price (ASP), (US$/Unit) & (2020-2031)

Figure 8. By Consumption Value, China Mucormycosis Treatment Drugs Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Mucormycosis Treatment Drugs Market Share of Global, 2020-2031

Figure 10. Global Mucormycosis Treatment Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Mucormycosis Treatment Drugs Key Participants, Market Share, 2024

Figure 12. Global Mucormycosis Treatment Drugs Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Mucormycosis Treatment Drugs Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Mucormycosis Treatment Drugs Production Market Share & Forecast by Region, 2020-2031

Figure 15. Mucormycosis Treatment Drugs Industry Chain

Figure 16. Mucormycosis Treatment Drugs Procurement Model

Figure 17. Mucormycosis Treatment Drugs Sales Model

Figure 18. Mucormycosis Treatment Drugs Sales Channels, Direct Sales, and Distribution

Figure 19. Injection

Figure 20. Oral

Figure 21. by Type, Global Mucormycosis Treatment Drugs Consumption Value, 2020-2031, US$ Million

Figure 22. by Type, Global Mucormycosis Treatment Drugs Consumption Value Market Share, 2020-2031

Figure 23. by Type, Global Mucormycosis Treatment Drugs Sales Quantity, 2020-2031, (K Units)

Figure 24. by Type, Global Mucormycosis Treatment Drugs Sales Quantity Market Share, 2020-2031

Figure 25. by Type, Global Mucormycosis Treatment Drugs Average Selling Price (ASP), 2020-2031, (US$/Unit)

Figure 26. Hospitals

Figure 27. Clinics

Figure 28. Others

Figure 29. by Application, Global Mucormycosis Treatment Drugs Consumption Value, 2020-2031, US$ Million

Figure 30. by Application, Global Mucormycosis Treatment Drugs Revenue Market Share, 2020-2031

Figure 31. by Application, Global Mucormycosis Treatment Drugs Sales Quantity, 2020-2031, (K Units)

Figure 32. by Application, Global Mucormycosis Treatment Drugs Sales Quantity Market Share, 2020-2031

Figure 33. by Application, Global Mucormycosis Treatment Drugs Price, 2020-2031, (US$/Unit)

Figure 34. By Region, Global Mucormycosis Treatment Drugs Consumption Value Market Share, 2020-2031

Figure 35. By Region, Global Mucormycosis Treatment Drugs Sales Quantity Market Share, 2020-2031

Figure 36. North America Mucormycosis Treatment Drugs Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 37. By Country, North America Mucormycosis Treatment Drugs Consumption Value Market Share, 2024

Figure 38. Europe Mucormycosis Treatment Drugs Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 39. By Country, Europe Mucormycosis Treatment Drugs Consumption Value Market Share, 2024

Figure 40. Asia Pacific Mucormycosis Treatment Drugs Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 41. By Country/Region, Asia Pacific Mucormycosis Treatment Drugs Consumption Value Market Share, 2024

Figure 42. South America Mucormycosis Treatment Drugs Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 43. By Country, South America Mucormycosis Treatment Drugs Consumption Value Market Share, 2024

Figure 44. Middle East & Africa Mucormycosis Treatment Drugs Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 45. United States Mucormycosis Treatment Drugs Sales Quantity, 2020-2031, (K Units)

Figure 46. by Type, United States Mucormycosis Treatment Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 47. by Application, United States Mucormycosis Treatment Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 48. Europe Mucormycosis Treatment Drugs Sales Quantity, 2020-2031, (K Units)

Figure 49. by Type, Europe Mucormycosis Treatment Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 50. by Application, Europe Mucormycosis Treatment Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 51. China Mucormycosis Treatment Drugs Sales Quantity, 2020-2031, (K Units)

Figure 52. by Type, China Mucormycosis Treatment Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 53. by Application, China Mucormycosis Treatment Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 54. Japan Mucormycosis Treatment Drugs Sales Quantity, 2020-2031, (K Units)

Figure 55. by Type, Japan Mucormycosis Treatment Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 56. by Application, Japan Mucormycosis Treatment Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 57. South Korea Mucormycosis Treatment Drugs Sales Quantity, 2020-2031, (K Units)

Figure 58. by Type, South Korea Mucormycosis Treatment Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 59. by Application, South Korea Mucormycosis Treatment Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 60. Southeast Asia Mucormycosis Treatment Drugs Sales Quantity, 2020-2031, (K Units)

Figure 61. by Type, Southeast Asia Mucormycosis Treatment Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 62. by Application, Southeast Asia Mucormycosis Treatment Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 63. India Mucormycosis Treatment Drugs Sales Quantity, 2020-2031, (K Units)

Figure 64. by Type, India Mucormycosis Treatment Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 65. by Application, India Mucormycosis Treatment Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 66. Middle East & Africa Mucormycosis Treatment Drugs Sales Quantity, 2020-2031, (K Units)

Figure 67. by Type, Middle East & Africa Mucormycosis Treatment Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 68. by Application, Middle East & Africa Mucormycosis Treatment Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 69. Research Methodology

Figure 70. Breakdown of Primary Interviews

Figure 71. Bottom-up Approaches

Figure 72. Top-down Approaches